Aspirin inhibits thrombin action on endothelial cells via up-regulation of aminopeptidase N/CD13 expression

Atherosclerosis

Volumn 183, Issue 1, 2005, Pages 49-55

  Kato, Midori ^a   Azuma, Hiroyuki ^a   Akaike, Masashi ^a   Iuchi, Takahiko ^a   Aihara, Ken Ichi ^a   Ikeda, Yasumasa ^a   Fujimura, Mitsunori ^a   Yoshida, Tomonori ^a   Yamaguchi, Hiroshi ^a   Hashizume, Shunji ^a   Matsumoto, Toshio ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Aminopeptidase N CD13; Aspirin; Endothelial cells; Thrombin

Indexed keywords

ACETYLSALICYLIC ACID; AMINOPEPTIDASE; BESTATIN; MESSENGER RNA; METALLOPROTEINASE; MICROSOMAL AMINOPEPTIDASE; REACTIVE OXYGEN METABOLITE; THROMBIN;

ARTICLE; ATHEROSCLEROSIS; ATTENUATION; CONTROLLED STUDY; DRUG INHIBITION; DRUG MECHANISM; ENDOTHELIUM CELL; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; STIMULATION; UMBILICAL VEIN; UPREGULATION;

ANTIGENS, CD13; ASPIRIN; CELLS, CULTURED; ENDOTHELIAL CELLS; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; ENZYME INDUCTION; FIBRINOLYTIC AGENTS; GENES, REPORTER; HUMANS; LEUCINE; PROTEASE INHIBITORS; REACTIVE OXYGEN SPECIES; RNA, MESSENGER; SUBTRACTION TECHNIQUE; THROMBIN; TRANSCRIPTION, GENETIC; TRANSFECTION; UMBILICAL VEINS;

EID: 26244468070     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2005.03.003     Document Type: Article

References (37)

1. S. Juul-Moller, N. Edvardsson, and B. Jahnmatz Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris, The Swedish Angina Pectoris Aspirin Trial (SAPAT) Group Lancet 340 1992 1421 1425
2. Antiplatelet Trialists' Collaboration Collaborative overview of randomised trials of antiplatelet therapy. I. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients BMJ 308 1994 81 106
3. E. Kopp, and S. Ghosh Inhibition of NF-kappa B by sodium salicylate and aspirin Science 265 1994 956 959
4. M. Grilli, M. Pizzi, M. Memo, and P. Spano Neuroprotection by aspirin and sodium salicylate through blockade of NF-kappa B activation Science 274 1996 1383 1385
5. M.J. Yin, Y. Yamamoto, and R.B. Gaynor The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta Nature 396 1998 77 80
6. Z. Dong, C. Huang, R.E. Brown, and W.Y. Ma Inhibition of activator protein 1 activity and neoplastic transformation by aspirin J Biol Chem 272 1997 9962 9970
7. C. Huang, W.Y. Ma, and D. Hanenberger Inhibition of ultraviolet B-induced activator protein-1 (AP-1) activity by aspirin in AP-1-luciferase transgenic mice J Biol Chem 272 1997 26325 26331
8. S. Oberle, T. Polte, A. Abate, H.P. Podhaisky, and H. Schroder Aspirin increases ferritin synthesis in endothelial cells: a novel antioxidant pathway Circ Res 82 1998 1016 1020
9. D.A. Jurivich, L. Sistonen, R.A. Kroes, and R.I. Morimoto Effect of sodium salicylate on the human heat shock response Science 255 1992 1243 1245
10. A. Kagawa, H. Azuma, M. Akaike, Y. Kanagawa, and T. Matsumoto Aspirin reduces apolipoprotein(a) (apo(a)) production in human hepatocytes by suppression of apo(a) gene transcription J Biol Chem 274 1999 34111 34115
11. D. Riemann, A. Kehlen, and J. Langner CD13 - not just a marker in leukemia typing Immunol Today 20 1999 83 88
12. B.S. Coller, P. Ward, and M. Ceruso Thrombin receptor activating peptides: importance of the N-terminal serine and its ionization state as judged by pH dependence, nuclear magnetic resonance spectroscopy, and cleavage by aminopeptidase M Biochemistry 31 1992 11713 11720
13. R. Ross The pathogenesis of atherosclerosis - an update N Engl J Med 314 1986 488 500
14. J. Fingerle, R. Johnson, A.W. Clowes, M.W. Majesky, and M.A. Reidy Role of platelets in smooth muscle cell proliferation and migration after vascular injury in rat carotid artery Proc Natl Acad Sci USA 86 1989 8412 8416
15. N.A. Nelken, S.J. Soifer, and J. O'Keefe Thrombin receptor expression in normal and atherosclerotic human arteries J Clin Invest 90 1992 1614 1621
16. J.M. Waugh, J. Li-Hawkins, and E. Yuksel Thrombomodulin overexpression to limit neointima formation Circulation 102 2000 332 337
17. T. Iuchi, M. Akaike, and T. Mitsui Glucocorticoid excess induces superoxide production in vascular endothelial cells and elicits vascular endothelial dysfunction Circ Res 92 2003 81 87
18. K. Aihara, H. Azuma, and M. Akaike Disruption of nuclear vitamin D receptor gene causes enhanced thrombogenicity in mice J Biol Chem 279 2004 35798 35802
19. A.T. Look, R.A. Ashmun, L.H. Shapiro, and S.C. Peiper Human myeloid plasma membrane glycoprotein CD13 (gp150) is identical to aminopeptidase N J Clin Invest 83 1989 1299 1307
20. L.H. Shapiro, R.A. Ashmun, W.M. Roberts, and A.T. Look Separate promoters control transcription of the human aminopeptidase N gene in myeloid and intestinal epithelial cells J Biol Chem 266 1991 11999 12007
21. H. Fujii, M. Nakajima, and I. Saiki Human melanoma invasion and metastasis enhancement by high expression of aminopeptidase N/CD13 Clin Exp Metastasis 13 1995 337 344
22. O.H. Lowry, N.J. Rosebrough, A.L. Farr, and R.J. Randall Protein measurement with the Folin phenol reagent J Biol Chem 193 1951 265 275
23. M.A. Shipp, and A.T. Look Hematopoietic differentiation antigens that are membrane-associated enzymes: cutting is the key Blood 82 1993 1052 1070
24. S.V. Bhagwat, J. Lahdenranta, and R. Giordano CD13/APN is activated by angiogenic signals and is essential for capillary tube formation Blood 97 2001 652 659
25. S.V. Bhagwat, N. Petrovic, Y. Okamoto, and L.H. Shapiro The angiogenic regulator CD13/APN is a transcriptional target of Ras signaling pathways in endothelial morphogenesis Blood 101 2003 1818 1826
26. A. Undas, R. Undas, J. Musial, and A. Szczeklik A low dose of aspirin (75 mg/day) lowers thrombin generation to a similar extent as a high dose of aspirin (300 mg/day) Blood Coagul Fibrinolysis 11 2000 231 234
27. J. Musial, A. Undas, R. Undas, J. Brozek, and A. Szczeklik Treatment with simvastatin and low-dose aspirin depresses thrombin generation in patients with coronary heart disease and borderline-high cholesterol levels Thromb Haemost 85 2001 221 225
28. A. Undas, K. Brummel, J. Musial, K.G. Mann, and A. Szczeklik Blood coagulation at the site of microvascular injury: effects of low-dose aspirin Blood 98 2001 2423 2431
29. C. Weber, W. Erl, A. Pietsch, and P.C. Weber Aspirin inhibits nuclear factor-kappa B mobilization and monocyte adhesion in stimulated human endothelial cells Circulation 91 1995 1914 1917
30. M.J. Vervoordeldonk, I.M. Pineda Torra, A.J. Aarsman, and H. van den Bosch Aspirin inhibits expression of the interleukin-1beta-inducible group II phospholipase A2 FEBS Lett 397 1996 108 112
31. P. Oeth, and N. Mackman Salicylates inhibit lipopolysaccharide-induced transcriptional activation of the tissue factor gene in human monocytic cells Blood 86 1995 4144 4152
32. D.N. Muller, V. Heissmeyer, and R. Dechend Aspirin inhibits NF-kappaB and protects from angiotensin II-induced organ damage FASEB J 15 2001 1822 1824
33. J.K. Kim, Y.J. Kim, and J.J. Fillmore Prevention of fat-induced insulin resistance by salicylate J Clin Invest 108 2001 437 446
34. Z. Gao, A. Zuberi, M.J. Quon, Z. Dong, and J. Ye Aspirin inhibits serine phosphorylation of insulin receptor substrate 1 in tumor necrosis factor-treated cells through targeting multiple serine kinases J Biol Chem 278 2003 24944 24950
35. N. Petrovic, S.V. Bhagwat, W.J. Ratzan, M.C. Ostrowski, and L.H. Shapiro CD13/APN transcription is induced by RAS/MAPK-mediated phosphorylation of Ets-2 in activated endothelial cells J Biol Chem 278 2003 49358 49368
36. B.S. Coller, K.T. Springer, and L.E. Scudder Substituting isoserine for serine in the thrombin receptor activation peptide SFLLRN confers resistance to aminopeptidase M-induced cleavage and inactivation J Biol Chem 268 1993 20741 20743
37. S.R. Coughlin Protease-activated receptors in vascular biology Thromb Haemost 86 2001 298 307